Meeting
2023 ASCO Genitourinary Cancers Symposium
Effect of body weight on standardized uptake values on 18F-DCFPyL (PSMA) PET/CT in patients with prostate cancer.
Authors
Ashwin Singh Parihar
Mallinckrodt Institute of Radiology, Washington University School of Medicine, Saint Louis, MO
Ashwin Singh Parihar , Lisa R Schmidt , John Crandall , Farrokh Dehdashti , Barry A. Siegel , Richard L. Wahl
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer - Advanced,Prostate Cancer - Localized
Sub Track
Diagnostics and Imaging
Citation
J Clin Oncol 41, 2023 (suppl 6; abstr 52)
DOI
10.1200/JCO.2023.41.6_suppl.52
Abstract #
52
Poster Bd #
B10
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Sequential metastasis-directed therapy (MDT) for oligometastatic prostate cancer (Oligo PCa) assessed by PET-based imaging.
First Author: Alberto Carretero-González
Poster
2019 Genitourinary Cancers Symposium
Clinical and molecular analysis of patients treated with prostate-specific membrane antigen (PSMA)-targeted radionuclide therapy.
First Author: Vincenza Conteduca
Poster
2018 Genitourinary Cancers Symposium
Biological significance of novel populations of prostate cancer circulating tumor cells (CTC).
First Author: Ian D. Davis
Poster
2024 ASCO Genitourinary Cancers Symposium
PSMA-based PET as an imaging biomarker of androgen receptor signaling in high-risk localized and locally advanced prostate cancer (PCa).
First Author: Keara English